Peer Review History
| Original SubmissionOctober 22, 2019 |
|---|
|
PONE-D-19-29500 The Efficacy of Predicting Death by the Loss of Intestinal Function PLOS ONE Dear Dr Bitner, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Although short, the manuscript reports on issues that impact a good number of labs in the field. However as it stands it is difficult to send for review because of formatting issues. Please remove the figure legend text from within teh Results section and add it to the end after the references. Same for the tables and their legends. Please move them to the respective figure and legend sections. It is useful if a photo of the "food straw" used was provided. ============================== We would appreciate receiving your revised manuscript by Dec 20 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Efthimios M. C. Skoulakis, PhD Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 3. Thank you for stating the following financial disclosure: "No -The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.".
* Please include your amended statements within your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-19-29500R1 The Efficacy of Predicting Death by the Loss of Intestinal Function PLOS ONE Dear Dr Bitner, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== There are a few technical issues that need to be thoroughly addressed as suggested by both reviewers. In fact the experimental protocol and methodological questions of reviewer 2 and the issues raised regarding replication have to be addressed thoroughly with new experiments if necessary. ============================== We would appreciate receiving your revised manuscript by Jan 16 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Efthimios M. C. Skoulakis, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a manuscript reporting on the reliability of using dyes as food supplements to predict death in Drosophila. In the original paper: Rera M, Clarck RI, Walker DW.M. 2012. Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila. Proc Natl Acad Sci U S A. 2012 Dec 26;109(52):21528-33, has been suggested that intestinal barrier dysfunction predicts impending death in individual flies. The underlying hypothesis here is that when the intestine epithelium brakes down during aging then the dye, consumed with the food, diffuses from the gut to the rest of the body via circulation and thus the fly exhibits full coloration; it becomes smurf. In contrast, the results of the present manuscript clearly demonstrate that this is not the case. By using different dyes at similar to the Rera et al, 2012 paper concentration the authors demonstrate that only a minor percentage of flies exhibit full body dye coloration (smurfs) and mostly one day prior to death or even the day of death. This suggests that the smurf phenotype is not a useful biomarker of death. The findings of this manuscript, previously published papers by the group and a recent paper Gaitanidis et al, 2019 (Gaitanidis A., Dimitriadou A., Dowse H., Sanyal S. Duch C., Consoulas C. (2019). Pre-death morbidity in Drosophila and its compression. Aging, 11:1850-1873) demonstrate that apart from the gradual decay during aging, fit flies may collapse and die within a very short time (sudden death). The process has been termed the death spiral or sudden death and can be fast. This is exactly demonstrated in the present manuscript. Few flies become smurf several days prior to death whereas others (the majority) only the day of death. That said, I firmly believe that this manuscript should be published. Minor comments 203 We 204 do note that the food used in our study has only 2.5 grams of dye per 100 mL of food whereas 205 Rera put 3.12 grams of dye in 100 mL of food [16]. -Please refer to the paper `Rera et al, 2012` than to one author. All authors worked for this publication. Furthermore, in the materials and methods section of the aforementioned paper is clearly mentioned that the dye concentration is 2.5% (wt/vol). Thus, remove or modify your claim. 154 the control treatments lived significantly longer then every other treatment. -Please correct. 213 integrity and become Smurfs andthose that don’t, but they fail to provide exact details on how 214 many individuals become s Smurfs prior to death. -Please correct -Add and refer to the Gaitanidis et al, 2019 paper (Gaitanidis A., Dimitriadou A., Dowse H., Sanyal S. Duch C., Consoulas C. (2019). Pre-death morbidity in Drosophila and its compression. Aging, 11:1850-1873). -The manuscript needs proof reading. Reviewer #2: This is a very (too) short manuscript that reports an interesting observation but it is lacking a lot of critical information. It is unclear how the experiments were done and it is impossible to replicate the experiments with the information provided. The authors do not indicate what is actually measured, stating only longevity. Is it the average, mean, max longevity? It is standard in the field of aging to provide all the data in separate tables (in supplemental data), like for instance Table S1 in PNAS 111(22):8137,2014. It is IMPERATIVE that the authors provide tables containing each experimental replicate for each dye and control with the corresponding sample size, average, median and max longevity, and logrank P values (% smurfs included but a second table would be better to be able to include all daily scorings done). Table 1 and 2 are very confusing and strongly suggest that the experiment have been done only once. The material and methods indicates that cohorts of about 56 flies were used but table 1 indicates for example that ~280 flies were exposed per Dye/Control which means that 56 flies from each population was used and based on the number used for each population in table 2 (for instance ACO) 383 flies is the number of flies needed for one experiment (control + 6 dyes: 56*7=392). It is also suspicious that figure 2 has error bars (no explanation in legend, is it SD, SE?) that are all exactly identical. This article cannot be published and I cannot properly evaluate it until the authors provide complete experimental details and data, and that the experiment has been replicated. The gender of the animals tested is also not provided but the statistical analysis section of the material and method does indicate that males and females were used. The authors performed an important control experiment to see if tapping affect longevity yet do not provide any data/figure from these experiments nor it is mentioned in the result, yet the discussion states on line 177 that the experiment show no detectable effects of taping. There is no justification to why the authors perform this test only with ACO females while the subsequent experiments use both gender and 4 additional genotypes. The authors do not report how the flies were collected (anesthesia or not, kind of anesthesia, duration of anesthesia and time window/age interval). The authors do not indicate how and if they ensure that each fly has actually consumed the food. From the material and method, I guess that the authors did check coloring of the gut but should clearly indicates that all flies did show a blue gut. It remains possible that the proportion of flies that are not “smurfing” consumed less food and consequently not enough dye is ingested to display color outside of the gut. The composition of the fly food used is not provided. Figure 1 and 4 should be combined together (method of delivery/monitoring, example of smurf flies). ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Laurent Seroude [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-19-29500R2 Predicting Death by the Loss of Intestinal Function PLOS ONE Dear Dr Bitner, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Although improved, the manuscript needs addition careful attention and thorough response to the comments and suggestions raised by reviewer #2 and pertain to the methodology and reproducibility of the data, both cardinally critical issues for publication. It is essential that they are thoroughly addressed as this would be the third revision of the manuscript! ============================== We would appreciate receiving your revised manuscript by Mar 08 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Efthimios M. C. Skoulakis, PhD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: All questions were addressed by the authors. This is a useful manuscript uncovering limitations of a technique used to predict death in flies. Conceptually, intestinal integrity decay during aging may not be the most common pathway to death in flies. Reviewer #2: The authors have largely addressed the comments of the reviewers and provided the technical details required for one to replicate the experiments, however, it remains very concerning that the authors still do not provide critical information to properly review this manuscript (max longevity and log rank p values). It is especially troubling that the authors still do not provide access to the data and respond with “we will deposit the raw data in DRYAD upon acceptance of the paper”. The review of scientific data must be done before an article is published and should not be provided upon acceptance of the paper. It is now clear that none of the experiments have been experimentally replicated and although the statistical analysis allows for “substantial replicate” it is not sufficient to ensure that the results presented are reproducible. The authors responded that “We did no analyses of the median or maximum longevity” yet states in the article: ”there were significant differences in mean longevity between all populations and their controls except CO and s93 (p=0.16”. For a given population, only one measurement (only one experimental replicate) is made with less than 30 individuals (per gender). The statistical validation of the experiment does not mean that the experiment is reproducible and certainly does not warrant that the resulting interpretation is biologically correct. The need for independent experimental replicate of those experiments is especially needed when the ACO longevity is obviously different between the tapping experiment (53-55 days) and the dye experiment (40 days). The lack of experimental replicate also applies to the tapping experiment that the authors have now clearly stated that they did it “to see if our methods for checking for Smurf flies would affect the mean longevity of the fly”. In this case the authors also uses an inappropriate method (t test). The authors still do not justify why they only tested the effect of taping only on the ACO population when the data show obvious differences in longevity of controls (and differences between control and dye treatments are not always significant). It cannot be concluded that the absence of effect on longevity by tapping of the ACO individuals would show that the taping has no effect on the longevity of the other populations. In the absence of experimental replicates, I am not confident that the data presented are reproducible and that the biological conclusions are scientifically valid and therefore I cannot recommend to accept this manuscript for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Laurent Seroude [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Predicting Death by the Loss of Intestinal Function PONE-D-19-29500R3 Dear Dr. Bitner, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Efthimios M. C. Skoulakis, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have provided additional analysis of their data that confirm the main findings. Therefore I believe that the manuscript should be accepted for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No |
| Formally Accepted |
|
PONE-D-19-29500R3 Predicting Death by the Loss of Intestinal Function Dear Dr. Bitner: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Efthimios M. C. Skoulakis Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .